Immunoprecise Antibodies Stock Volatility
| IPA Stock | USD 1.22 0.03 2.40% |
Immunoprecise Antibodies holds Efficiency (Sharpe) Ratio of -0.0473, which attests that the entity had a -0.0473% return per unit of risk over the last 3 months. Immunoprecise Antibodies exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunoprecise Antibodies' Standard Deviation of 5.83, market risk adjusted performance of 0.2728, and Risk Adjusted Performance of (0.01) to validate the risk estimate we provide. Key indicators related to Immunoprecise Antibodies' volatility include:
720 Days Market Risk | Chance Of Distress | 720 Days Economic Sensitivity |
Immunoprecise Antibodies Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Immunoprecise daily returns, and it is calculated using variance and standard deviation. We also use Immunoprecise's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Immunoprecise Antibodies volatility.
Immunoprecise |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Immunoprecise Antibodies can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Immunoprecise Antibodies at lower prices. For example, an investor can purchase Immunoprecise stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Immunoprecise Antibodies' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Immunoprecise Stock
| 0.61 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.6 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.58 | ELYM | Eliem Therapeutics | PairCorr |
| 0.55 | XFOR | X4 Pharmaceuticals Buyout Trend | PairCorr |
| 0.49 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.46 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.44 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
Immunoprecise Antibodies Market Sensitivity And Downside Risk
Immunoprecise Antibodies' beta coefficient measures the volatility of Immunoprecise stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Immunoprecise stock's returns against your selected market. In other words, Immunoprecise Antibodies's beta of -0.54 provides an investor with an approximation of how much risk Immunoprecise Antibodies stock can potentially add to one of your existing portfolios. Immunoprecise Antibodies exhibits very low volatility with skewness of 1.55 and kurtosis of 3.64. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Immunoprecise Antibodies' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Immunoprecise Antibodies' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Immunoprecise Antibodies Demand TrendCheck current 90 days Immunoprecise Antibodies correlation with market (NYSE Composite)Immunoprecise Beta |
Immunoprecise standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 5.75 |
It is essential to understand the difference between upside risk (as represented by Immunoprecise Antibodies's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Immunoprecise Antibodies' daily returns or price. Since the actual investment returns on holding a position in immunoprecise stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Immunoprecise Antibodies.
Using Immunoprecise Put Option to Manage Risk
Put options written on Immunoprecise Antibodies grant holders of the option the right to sell a specified amount of Immunoprecise Antibodies at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Immunoprecise Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Immunoprecise Antibodies' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Immunoprecise Antibodies will be realized, the loss incurred will be offset by the profits made with the option trade.
Immunoprecise Antibodies' PUT expiring on 2024-05-17
Profit |
| Immunoprecise Antibodies Price At Expiration |
Current Immunoprecise Antibodies Insurance Chain
| Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | 2024-05-17 PUT at $2.5 | -0.3544 | 0.1877 | 111 | 2024-05-17 | 0.05 - 1.8 | 1.27 | View |
Immunoprecise Antibodies Stock Volatility Analysis
Volatility refers to the frequency at which Immunoprecise Antibodies stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Immunoprecise Antibodies' price changes. Investors will then calculate the volatility of Immunoprecise Antibodies' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Immunoprecise Antibodies' volatility:
Historical Volatility
This type of stock volatility measures Immunoprecise Antibodies' fluctuations based on previous trends. It's commonly used to predict Immunoprecise Antibodies' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Immunoprecise Antibodies' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Immunoprecise Antibodies' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Immunoprecise Antibodies Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Immunoprecise Antibodies Projected Return Density Against Market
Considering the 90-day investment horizon Immunoprecise Antibodies has a beta of -0.5439 . This usually indicates as returns on the benchmark increase, returns on holding Immunoprecise Antibodies are expected to decrease at a much lower rate. During a bear market, however, Immunoprecise Antibodies is likely to outperform the market.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Immunoprecise Antibodies or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Immunoprecise Antibodies' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Immunoprecise stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Immunoprecise Antibodies has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Predicted Return Density |
| Returns |
What Drives an Immunoprecise Antibodies Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Immunoprecise Antibodies Stock Risk Measures
Considering the 90-day investment horizon the coefficient of variation of Immunoprecise Antibodies is -2113.49. The daily returns are distributed with a variance of 33.03 and standard deviation of 5.75. The mean deviation of Immunoprecise Antibodies is currently at 3.71. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.62
α | Alpha over NYSE Composite | -0.1 | |
β | Beta against NYSE Composite | -0.54 | |
σ | Overall volatility | 5.75 | |
Ir | Information ratio | -0.04 |
Immunoprecise Antibodies Stock Return Volatility
Immunoprecise Antibodies historical daily return volatility represents how much of Immunoprecise Antibodies stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company has volatility of 5.7475% on return distribution over 90 days investment horizon. By contrast, NYSE Composite accepts 0.6372% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Immunoprecise Antibodies Volatility
Volatility is a rate at which the price of Immunoprecise Antibodies or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Immunoprecise Antibodies may increase or decrease. In other words, similar to Immunoprecise's beta indicator, it measures the risk of Immunoprecise Antibodies and helps estimate the fluctuations that may happen in a short period of time. So if prices of Immunoprecise Antibodies fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 4.1 M | 4.4 M | |
| Market Cap | 201.9 K | 191.8 K |
Immunoprecise Antibodies' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Immunoprecise Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Immunoprecise Antibodies' price varies over time.
3 ways to utilize Immunoprecise Antibodies' volatility to invest better
Higher Immunoprecise Antibodies' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Immunoprecise Antibodies stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Immunoprecise Antibodies stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Immunoprecise Antibodies investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Immunoprecise Antibodies' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Immunoprecise Antibodies' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Immunoprecise Antibodies Investment Opportunity
Immunoprecise Antibodies has a volatility of 5.75 and is 8.98 times more volatile than NYSE Composite. 50 percent of all equities and portfolios are less risky than Immunoprecise Antibodies. You can use Immunoprecise Antibodies to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Immunoprecise Antibodies to be traded at $1.1712 in 90 days.Good diversification
The correlation between Immunoprecise Antibodies and NYA is -0.06 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immunoprecise Antibodies and NYA in the same portfolio, assuming nothing else is changed.
Immunoprecise Antibodies Additional Risk Indicators
The analysis of Immunoprecise Antibodies' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Immunoprecise Antibodies' investment and either accepting that risk or mitigating it. Along with some common measures of Immunoprecise Antibodies stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 0.2728 | |||
| Mean Deviation | 3.86 | |||
| Coefficient Of Variation | (4,387) | |||
| Standard Deviation | 5.83 | |||
| Variance | 34.02 | |||
| Information Ratio | (0.04) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Immunoprecise Antibodies Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Immunoprecise Antibodies as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Immunoprecise Antibodies' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Immunoprecise Antibodies' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Immunoprecise Antibodies.
When determining whether Immunoprecise Antibodies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immunoprecise Antibodies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immunoprecise Antibodies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immunoprecise Antibodies Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunoprecise Antibodies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Immunoprecise Stock refer to our How to Trade Immunoprecise Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Immunoprecise Stock analysis
When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.939 | Quarterly Revenue Growth 0.203 | Return On Assets (0.11) | Return On Equity (0.26) |
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunoprecise Antibodies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.